Ursodeoxycholic acid sodium

CAS No. 2898-95-5

Ursodeoxycholic acid sodium( Ursodeoxycholate sodium | UDCA sodium | UDCA Na | Sodium Ursodeoxycholate | Ursodeoxycholic Acid (sodium salt) )

Catalog No. M27933 CAS No. 2898-95-5

Ursodeoxycholic acid sodium is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ursodeoxycholic acid sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    Ursodeoxycholic acid sodium is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,
  • Description
    Ursodeoxycholic acid sodium is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,
  • In Vitro
    ——
  • In Vivo
    Ursodeoxycholic acid (50, 150, and 450 mg/kg; p.o.; daily for 21 days) sodium results in weight loss in C57BL/6J wildtype mice. Animal Model:5 week old C57BL/6J WT mice (male and female)Dosage:50, 150, and 450 mg/kg dissolved in corn oilAdministration:Oral gavage; daily for 21 days Result:Mice in the 50 and 450 mg/kg groups sustained significant weight loss within a week. At 50 mg/kg, this weight loss persisted over the course of the experiment. At 450 mg/kg, initially weight loss was noted during the first and third week of ursodiol administration. At 150 mg/kg, it did not have significantly different weights compared to the untreated mice.
  • Synonyms
    Ursodeoxycholate sodium | UDCA sodium | UDCA Na | Sodium Ursodeoxycholate | Ursodeoxycholic Acid (sodium salt)
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    FXR
  • Recptor
    Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2898-95-5
  • Formula Weight
    414.562
  • Molecular Formula
    C24H39NaO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (301.53 mM)
  • SMILES
    [H][C@@]12CC[C@H]([C@H](C)CCC(=O)O[Na])[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C[C@]2([H])C[C@H](O)CC[C@]12C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tehrani K , Hashemi M , Hassan M , et al. Synthesis and antibacterial activity of Schiff bases of 5-substituted isatins. Chinese Chemical Letters, 2016.
molnova catalog
related products
  • MFA-1

    MFA-1 (Merck FXR agonist 1) is a potent, synthetic FXR agonist with EC50 of 16.9 nM in coactivator recruitment assays.

  • GSK-2324

    GSK-2324 (GSK2324)?is a potent, selective, full FXR agonist with EC50 of 120 nM in FRET assay.

  • Cilofexor

    Cilofexor (GS-9674, GS9674, PX-104)?is a novel specific, non-steroidal farnesoid X receptor (FXR) agonist that reduces liver fibrosis and ameliorates portal hypertension in rat NASH models.